Nothing Special   »   [go: up one dir, main page]

NO974924D0 - Modifiserte polypeptider med öket immunogenisitet - Google Patents

Modifiserte polypeptider med öket immunogenisitet

Info

Publication number
NO974924D0
NO974924D0 NO974924A NO974924A NO974924D0 NO 974924 D0 NO974924 D0 NO 974924D0 NO 974924 A NO974924 A NO 974924A NO 974924 A NO974924 A NO 974924A NO 974924 D0 NO974924 D0 NO 974924D0
Authority
NO
Norway
Prior art keywords
modified polypeptides
increased immunogenicity
immunogenicity
increased
polypeptides
Prior art date
Application number
NO974924A
Other languages
English (en)
Other versions
NO974924L (no
Inventor
Nicolas Joseph Fasel
Christophe Dominique Reymond
Original Assignee
Rmf Dictagene Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rmf Dictagene Sa filed Critical Rmf Dictagene Sa
Publication of NO974924D0 publication Critical patent/NO974924D0/no
Publication of NO974924L publication Critical patent/NO974924L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • C07K14/445—Plasmodium
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
NO974924A 1995-04-25 1997-10-24 Modifiserte polypeptider med öket immunogenisitet NO974924L (no)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP95201066 1995-04-25
US08/428,616 US6113917A (en) 1995-04-25 1995-04-25 Modified polypeptides for enhanced immunogenicity
NL1001348A NL1001348C2 (en) 1995-04-25 1995-10-05 Polypeptide comprising glycosyl-phosphatidyl:inositol structure
PCT/EP1996/001744 WO1996034105A1 (en) 1995-04-25 1996-04-25 Modified polypeptides for enhanced immunogenicity

Publications (2)

Publication Number Publication Date
NO974924D0 true NO974924D0 (no) 1997-10-24
NO974924L NO974924L (no) 1997-12-19

Family

ID=26139248

Family Applications (1)

Application Number Title Priority Date Filing Date
NO974924A NO974924L (no) 1995-04-25 1997-10-24 Modifiserte polypeptider med öket immunogenisitet

Country Status (15)

Country Link
US (1) US6113917A (no)
EP (1) EP0826050A1 (no)
JP (1) JPH11504215A (no)
AU (1) AU714808B2 (no)
BR (1) BR9604989A (no)
CA (1) CA2218987A1 (no)
CZ (1) CZ291013B6 (no)
HU (1) HUP9802238A3 (no)
IL (1) IL118021A0 (no)
NL (1) NL1001348C2 (no)
NO (1) NO974924L (no)
NZ (1) NZ307195A (no)
PL (1) PL323078A1 (no)
WO (1) WO1996034105A1 (no)
ZA (1) ZA963269B (no)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2249097A (en) * 1996-01-29 1997-08-20 Georgetown University Malaria vaccine based upon the addition of a msa1 peptide
AUPP589398A0 (en) * 1998-09-14 1998-10-08 Walter And Eliza Hall Institute Of Medical Research, The Immunogenic compositions and uses thereof
AUPP675898A0 (en) * 1998-10-27 1998-11-19 Walter And Eliza Hall Institute Of Medical Research, The A method of activating t cells and agents useful for same
IL161296A0 (en) * 2001-10-13 2004-09-27 Asterion Ltd Glycosylphosphatidylinositol containing polypeptides
US20030171260A1 (en) * 2002-03-11 2003-09-11 Nelson Deanna Jean Compositions and methods utilizing hydroxamates to scavenge oxidant toxins
EP1545599B1 (en) 2002-07-26 2015-04-29 The Walter And Eliza Hall Institute Of Medical Research Immunogenic compositions and diagnostic and therapeutic uses thereof
EP1616010A2 (en) * 2003-04-09 2006-01-18 Asterion Limited Cytokine polypeptides and antibodies containing a signal sequence for the attachment of glycosylphosphatidylinositol
US20080026008A1 (en) * 2006-07-27 2008-01-31 Clark Tibbs Bacteriophage DNA vaccine vector
KR20240021211A (ko) * 2021-06-10 2024-02-16 얀센 바이오테크 인코포레이티드 Klk2-gpi 융합 단백질에 대한 핵산 코딩, 재조합 세포 및 이의 용도

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8905857D0 (en) * 1989-03-14 1989-04-26 Hoffmann La Roche Plasmodium merozoite rhoptries antigen
NL9100869A (nl) * 1991-05-17 1992-12-16 Univ Lausanne Dictyostelide expressievector en werkwijze voor het tot expressie brengen van een gewenst eiwit.
BR9400600A (pt) * 1994-02-17 1995-10-24 Finep Financiadora De Estudos Processos para produção de uma protéina recombinante e/ou de glicosilfosfatidilinositol (GPI) em células de microorganismos eucariontes e para a obtenção de leveduras de S. cerevisae; célula de levedura sequência de nucleotídios; meio de cultura; medicamento ou vacina; e produto dos ditos processos

Also Published As

Publication number Publication date
NO974924L (no) 1997-12-19
AU714808B2 (en) 2000-01-13
CA2218987A1 (en) 1996-10-31
HUP9802238A3 (en) 2000-03-28
BR9604989A (pt) 1999-11-30
NL1001348C2 (en) 1996-10-28
PL323078A1 (en) 1998-03-02
US6113917A (en) 2000-09-05
AU5648196A (en) 1996-11-18
WO1996034105A1 (en) 1996-10-31
ZA963269B (en) 1996-10-25
JPH11504215A (ja) 1999-04-20
HUP9802238A2 (hu) 1999-01-28
EP0826050A1 (en) 1998-03-04
NZ307195A (en) 1999-07-29
CZ337897A3 (cs) 1998-04-15
CZ291013B6 (cs) 2002-11-13
IL118021A0 (en) 1996-08-04

Similar Documents

Publication Publication Date Title
DK0809996T3 (da) Interferonkonjugater
DE59509790D1 (de) Winkelsensor
BR9608046A (pt) Sensor
NO976058L (no) Rekombinant mistellectin
BR9508433A (pt) Peptídeos
NO974924L (no) Modifiserte polypeptider med öket immunogenisitet
FI971485A0 (fi) Sits
ATA159897A (de) Sensor
EP0698666A3 (en) Modified epimorphin
FI98105B (fi) Mikroliuska-aaltoputkisiirtymä
ATA20993A (de) Heizgerät
FI2165U1 (fi) Skyddande trosor med aoteranvaendbar sugdel
DE69414190D1 (de) Kombiniertes Heizgerät
AT400192B (de) Heizgerät
FI974362A (fi) SMAW-svetsning med kontinuerlig hoegfrekvens
DE69434900D1 (de) Menschliche chemokin-polypeptide
SE9502007D0 (sv) Novel polypeptides
LT2401B (lt) Garintuvas
SE9601085D0 (sv) Novel polypeptides
FIU950030U0 (fi) Med en stol hopkopplingsbart underlag foer en dators tangentbord
KR940020160U (ko) 온장고
FI1936U1 (fi) Skaerplaoda med raklam
FI2178U1 (fi) Baeddsoffa/faotoelj med laoda foer saengklaeder
FI2052U1 (fi) Med skaft foersett skodon
KR970004604U (ko) 개선된 형상구조

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application